Good Life Advisors LLC Acquires New Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Good Life Advisors LLC acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,474 shares of the company’s stock, valued at approximately $223,000.

A number of other institutional investors also recently added to or reduced their stakes in DOCU. Avior Wealth Management LLC raised its stake in shares of DocuSign by 36.5% in the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after purchasing an additional 145 shares during the last quarter. Linden Thomas Advisory Services LLC raised its stake in shares of DocuSign by 1.1% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock worth $1,218,000 after purchasing an additional 149 shares during the last quarter. J.W. Cole Advisors Inc. raised its stake in shares of DocuSign by 2.0% in the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after purchasing an additional 155 shares during the last quarter. Optimist Retirement Group LLC raised its stake in shares of DocuSign by 3.8% in the third quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after purchasing an additional 161 shares during the last quarter. Finally, Covestor Ltd raised its stake in shares of DocuSign by 5.8% in the third quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after purchasing an additional 182 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

DocuSign Price Performance

DocuSign stock opened at $83.96 on Friday. The stock has a market capitalization of $16.96 billion, a PE ratio of 17.31, a price-to-earnings-growth ratio of 6.98 and a beta of 0.89. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The business has a 50 day simple moving average of $91.94 and a 200-day simple moving average of $76.27.

Analysts Set New Price Targets

Several research analysts have recently issued reports on DOCU shares. Robert W. Baird raised their price objective on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. JMP Securities restated a “market outperform” rating and issued a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Jefferies Financial Group lifted their price target on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, JPMorgan Chase & Co. lifted their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, DocuSign has a consensus rating of “Hold” and an average price target of $92.45.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at $6,765,251.90. The trade was a 9.32 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Daniel D. Springer sold 581,588 shares of DocuSign stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares in the company, valued at $87,959,967.20. This represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 693,773 shares of company stock worth $66,727,926 over the last three months. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.